Covid Kit Faq

Frequently Asked Questions


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is caused by the Corona virus 2019 (COVID-19), a new strain of coronavirus that has not been previously known to infect humans. The virus is the cause of outbreaks of respiratory illness in multiple locations around the world, including the U.S.


For the most up to date information on COVID-19, please visit the CDC Coronavirus Disease 2019 (COVID-19) general webpage: https://www.cdc.gov/COVID19


Individuals with COVID-19 have had a wide range of symptoms reported - ranging from mild symptoms to severe illness.


According to the CDC, symptoms may appear 2-14 days after exposure to the virus. According to the CDC, people with these symptoms may have COVID-19:


  • Cough
  • Shortness of breath or difficulty breathing
  • Fever
  • Chills
  • Muscle pain
  • Sore throat
  • New loss of taste or smell

This list is not all possible symptoms. Other less common symptoms have been reported, including gastrointestinal symptoms like nausea, vomiting, or diarrhea.


For the most up to date information on COVID-19, please visit the CDC Coronavirus Disease 2019 (COVID-19) general webpage: https://www.cdc.gov/COVID19


CRL RAPID RESPONSE™ is a saliva-based molecular test, which is authorized by the FDA under an Emergency Use Authorization (EUA), that can be self-collected and shipped to our lab when determined to be appropriate by a healthcare provider. Results of the test can confirm if the virus is detected in the saliva of an individual.


Please contact customer service at CTsupport@crlcorp.com.


Please visit crlclear.com to register your kit. For a step-by-step video tutorial of the kit registration and sample collection process, please visit www.crlcorp.com/covid-19-testing/videos


NOTE: The laboratory will be unable to process your sample unless the kit is registered at crlclear.com. For molecular saliva-based tests, make sure to adhere barcode label sticker to the saliva tube before shipping sample to the lab.


If the camera on your mobile device is not reading the barcode, please input the barcode number manually.


Your kit includes a transport bag and a pre-labeled Clinical Reference Laboratory transport box. Package your sample as instructed and drop off at any FedEx Ship Location. Or you can request that your sample be picked up by scheduling a time with FedEx. In the United States, call FedEx at 1-800-463-3339 for pickup. Specify you have a prepaid shipment for overnight delivery. Note: Saliva samples must be shipped within 24 hours of collection.


If you live in the Kansas City Metro area, samples can be dropped off at our laboratory in Lenexa, KS. Click here for map and additional information


Typically, results are available within 48 hours once received at the laboratory.


Your result will be delivered directly to you via phone - mobile or landline - as soon as it is available. If you provided a telephone number during registration, you will be contacted via text, or voice message when the result is available. Before viewing the result, you will be prompted to complete a dual factor authentication process.


Molecular results to determine active virus are reported detected (positive) or non-detected (negative). Saliva-based molecular testing provides evidence of an active, or recent infection. The Rapid Response test does not provide a quantitative level of the virus or indicate the severity of the infection.


Samples must be received by the lab within six months of kit purchase date.


Your health insurance company will determine whether you can be reimbursed for your test. To assist you, you will be given the opportunity to download an invoice after you receive your test results that you can present to your insurance company. Please note that CRL does not participate in Medicare or Medicaid, so your test may not be reimbursable under those programs. CRL cannot guarantee that your test will be reimbursable.

This test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by Clinical Reference Laboratory, Inc. located in Lenexa, KS. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.


Copyright 2020 Clinical Reference Laboratory, Inc.